PubMed Horne, C., Supramaniam, A., Lamont, B., Parkinson, J., Park, J.E., Vath, J., et al
A useful way to frame it is to compare protocol safety to signal-to-noise control in an assay
It is believed to contribute to fat digestion, while also reducing inflammation and swelling
When activated, these receptors trigger several beneficial effects: Enhanced insulin secretion in response to elevated blood glucose levels Suppression of glucagon release , reducing hepatic glucose production Delayed gastric emptying , which promotes satiety and reduces appetite Direct effects on appetite centres in the hypothalamus, leading to reduced food intake Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are all FDA-approved for weight loss
These studies dont yet prove causation, but the patterns they reveal are concerning enough to warrant caution